Business Context and Reporting Period
This Form 8-K Current Report was filed by Accuray Incorporated on October 25, 2021. The filing serves as a Regulation FD disclosure regarding an upcoming Analyst & Investor Meeting scheduled for the same date in conjunction with the American Society of Radiation Oncology (ASTRO) Annual Meeting.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notification of an investor event and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing solely announces the timing and format of the investor presentation.
Guidance, Outlook, and Management Commentary
- Event Details: The Investor Meeting is scheduled for October 25, 2021, beginning at 3:00 PM CT (4:00 PM ET). It will be held both in person at the ASTRO meeting and on a virtual platform.
- Content Focus: Management intends to present slides (Exhibit 99.1) discussing the Company's technologies and long-term business and growth strategies.
- Availability: A replay of the meeting and the presentation slides will be available on the Company's investor relations website following the event.
- Legal Status: The information in this report and Exhibit 99.1 is furnished pursuant to Item 7.01 and is not deemed "filed" under Section 18 of the Exchange Act.
Key Facts for Investor Verification
- Verify the availability of the management presentation slides (Exhibit 99.1) on the Accuray investor relations website.
- Confirm the specific details of the long-term growth strategies and technology updates presented during the October 25, 2021 meeting.
- Note that this filing does not contain audited financial data; refer to the most recent 10-Q or 10-K for financial metrics.